Calithera Biosciences (NASDAQ:CALA) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report report published on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

CALA stock opened at $0.02 on Tuesday. Calithera Biosciences has a 12 month low of $0.01 and a 12 month high of $0.50. The firm’s 50-day moving average is $0.02 and its 200 day moving average is $0.03.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.